Physician

Vijaya S Velury, M.D.

According to 2025 Medicare claims, Vijaya Velury, M.D. (NPI: 1518915750) practices cardiology in the Lawton, OK market, with the plurality of this provider's patient population coming from Comanche, OK. This provider's primary affiliated billing organization is COMANCHE COUNTY HOSPITAL AUTHORITY (NPI: 1003155821; TIN: 736061037) and primary practice location at 73505-6378. Velury is affiliated with the Lifecare ACO LLC (ACO ID: A3644), participating under the MSSP model.

Velury's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,719 traditional Medicare patients, billed 4,748 HCPCS/CPT codes, and received $207,992 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,970 prescription claims across 619 beneficiaries totaling $575,149 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 22 claims. Open Payments data shows 24 records totaling $574. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $284,400 to $575,149. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,437 to $5,625.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,515	5,809	$290,676
2016	1,905	6,394	$285,469
2017	2,106	6,850	$316,615
2018	2,093	6,494	$291,433
2019	2,023	6,540	$298,981
2020	1,718	5,251	$276,127
2021	1,515	4,769	$268,964
2022	1,537	4,235	$209,322
2023	1,773	4,852	$227,614
2024	1,719	4,748	$207,992

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	443	5,199	$284,400
2016	450	5,210	$297,281
2017	451	5,083	$332,313
2018	464	4,492	$361,564
2019	537	4,082	$389,926
2020	601	4,540	$436,919
2021	616	4,251	$481,710
2022	588	3,830	$471,045
2023	552	3,713	$477,902
2024	619	3,970	$575,149

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	44	$3,428
2016	N/R	34	$1,722
2017	N/R	34	$881
2018	N/R	45	$1,125
2019	N/R	35	$972
2020	N/R	22	$985
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	507	733	$66
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	388	400	$46
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	451	547	$44
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	162	162	$15
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	735	1,076	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	289	16,455	$311,280
Entresto	Sacubitril/Valsartan	62	3,739	$76,281
Xarelto	Rivaroxaban	57	3,630	$63,445
Multaq	Dronedarone Hcl	12	660	$16,753
Farxiga	Dapagliflozin Propanediol	11	870	$12,641

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$574	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vijaya S. Velury, M.D.?

Tedicare shows public-source Medicare data for Vijaya S. Velury, M.D. (NPI 1518915750), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vijaya S. Velury, M.D. have ACO affiliation data?

Vijaya S. Velury, M.D. is shown with ACO affiliation data for Lifecare ACO LLC (MSSP, ACO ID A3644).

What billing organization is linked to Vijaya S. Velury, M.D.?

Vijaya S. Velury, M.D. is linked to COMANCHE COUNTY HOSPITAL AUTHORITY (billing NPI 1003155821) in the available physician profile data.

Does Vijaya S. Velury, M.D. have Open Payments data?

Vijaya S. Velury, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.